triazoles has been researched along with isoniazid in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (5.88) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (29.41) | 29.6817 |
2010's | 9 (52.94) | 24.3611 |
2020's | 2 (11.76) | 2.80 |
Authors | Studies |
---|---|
BALLONOFF, LB; FEINSTEIN, RN; SEAHOLM, JE | 1 |
Cabantchik, ZI; Hershko, CM; Konijn, AM; Link, GM | 1 |
Ammosova, T; Charles, S; Debebe, Z; Gordeuk, VR; Jerebtsova, M; Kurantsin-Mills, J; Nekhai, S; Niu, X; Ray, PE; Richardson, DR | 1 |
Fairbanks, AJ; Long, H; Sim, E; Wilkinson, BL | 1 |
Brilhante, RS; Cordeiro, Rde A; de Camargo, ZP; de Lima, RA; Medrano, DJ; Monteiro, AJ; Rocha, MF; Sidrim, JJ; Tavares, JL | 1 |
Bayrak, H; Demirbas, A; Demirbas, N; Karaoglu, SA | 1 |
Baltas, M; Bedos-Belval, F; Constant, P; Daffé, M; De, P; Duran, H; Koumba Yoya, G; Saffon, N | 1 |
Deng, XQ; Quan, LN; Quan, ZS; Song, MX; Wei, CX | 1 |
Brilhante, RS; Caetano, EP; Castelo-Branco, Dde S; Cordeiro, Rde A; de Lima, RA; Fechine, MA; Marques, FJ; Mesquita, JR; Monteiro, AJ; Mourão, CI; Ribeiro, JF; Rocha de Castro E Silva, K; Rocha, FA; Rocha, MF; Sidrim, JJ | 1 |
Aguiar, AC; Bastos, MM; Bezerra, FA; Boechat, N; Camilo, AL; Costa, CC; da Silva, GP; da Silva, NV; de C da Silva, F; de Lourdes G Ferreira, M; Dos S Costa, M; Ferreira, SB; Ferreira, VF; Krettli, AU; Lourenço, MC; Martins, PR; Pinto, AC; Teixeira, BM | 1 |
Boechat, N | 1 |
Khare, G; Kidwai, S; Kumar, D; Rawat, DS; Singh, R; Tyagi, AK | 1 |
Bai, X; Deng, Q; Li, Z; Liu, Y; Wang, J; Wang, Y; Zhang, G; Zhou, L | 1 |
Abdel-Hamid, MK; Abdelrahman, MH; Abdu-Allah, HH; Aboul-Fadl, T; Reshma, RS; Sriram, D; Yogeeswari, P; Youssif, BG | 1 |
Mahendran, G; Vijayan, R | 1 |
Kraft, WK; Lam, E; Schaefer, J; Zhan, T; Zheng, R | 1 |
Dixit, PP; Haval, KP; Haval, NB; Kasare, SL; Khedkar, VM; Patil, PS; Rekha, EM; Sriram, D | 1 |
1 trial(s) available for triazoles and isoniazid
Article | Year |
---|---|
Twice-Daily Doravirine Overcomes the Interaction Effect from Once-Weekly Rifapentine and Isoniazid in Healthy Volunteers.
Topics: Adolescent; Adult; Antitubercular Agents; Area Under Curve; Drug Administration Schedule; Drug Interactions; Female; Healthy Volunteers; HIV Infections; Humans; Isoniazid; Male; Middle Aged; Prospective Studies; Pyridones; Reverse Transcriptase Inhibitors; Rifampin; Triazoles; Tuberculosis; Young Adult | 2020 |
16 other study(ies) available for triazoles and isoniazid
Article | Year |
---|---|
EFFECT ON CATALASE IN VIVO AND IN VITRO OF COMPOUNDS RELATED TO AMINOTRIAZOLE. ANL-6823.
Topics: Amitrole; Azides; Azoles; Catalase; Enzyme Inhibitors; Erythrocytes; Imidazoles; In Vitro Techniques; Isoniazid; Kidney; Liver; Oxadiazoles; Oxazoles; Oxidation-Reduction; Pentylenetetrazole; Pharmacology; Pyrazoles; Rats; Research; Thiazoles; Triazoles | 1964 |
Iron chelation therapy.
Topics: Administration, Oral; Benzoates; beta-Thalassemia; Chelation Therapy; Chemical and Drug Induced Liver Injury; Deferasirox; Deferiprone; Deferoxamine; Drug Therapy, Combination; Humans; Infusions, Intravenous; Iron Chelating Agents; Iron Overload; Isoniazid; Pyridones; Pyridoxal; Survival; Triazoles | 2005 |
Iron chelators ICL670 and 311 inhibit HIV-1 transcription.
Topics: Benzoates; Cells, Cultured; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 9; Deferasirox; Gene Expression Regulation, Viral; HIV-1; Humans; Iron; Iron Chelating Agents; Isoniazid; Transcription, Genetic; Triazoles; Virus Replication | 2007 |
Synthesis of Arabino glycosyl triazoles as potential inhibitors of mycobacterial cell wall biosynthesis.
Topics: Antitubercular Agents; Arabinose; Cell Wall; Glycosides; Isoniazid; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium bovis; Structure-Activity Relationship; Triazoles | 2008 |
In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii.
Topics: Amphotericin B; Antifungal Agents; Antitubercular Agents; Caspofungin; Coccidioides; Coccidioidomycosis; Drug Synergism; Echinocandins; Ethambutol; Fluconazole; Humans; Isoniazid; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrazinamide; Pyrimidines; Triazoles; Voriconazole | 2009 |
Synthesis of some new 1,2,4-triazoles starting from isonicotinic acid hydrazide and evaluation of their antimicrobial activities.
Topics: Anti-Infective Agents; Bacteria; Isoniazid; Mannich Bases; Microbial Sensitivity Tests; Molecular Structure; Oxadiazoles; Structure-Activity Relationship; Triazoles; Yeasts | 2009 |
Design, synthesis, and biological evaluation of new cinnamic derivatives as antituberculosis agents.
Topics: Amides; Antitubercular Agents; Cinnamates; Crystallography, X-Ray; Drug Design; Drug Resistance, Bacterial; Hydrazines; Isoniazid; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Mycolic Acids; Phthalazines; Stereoisomerism; Structure-Activity Relationship; Triazoles | 2011 |
Synthesis and anticonvulsant activity of 7-phenyl-6,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidin-5(4H)-ones and their derivatives.
Topics: 3-Mercaptopropionic Acid; Animals; Anticonvulsants; Bicuculline; Electroshock; Isoniazid; Mice; Pentylenetetrazole; Pyrimidinones; Seizures; Semicarbazides; Structure-Activity Relationship; Triazoles | 2011 |
Synergistic effect of antituberculosis drugs and azoles in vitro against Histoplasma capsulatum var. capsulatum.
Topics: Antitubercular Agents; Drug Combinations; Drug Interactions; Ethambutol; Fluconazole; Histoplasma; Isoniazid; Itraconazole; Pyrazinamide; Pyrimidines; Triazoles; Voriconazole | 2011 |
Novel 1,2,3-triazole derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain.
Topics: Antitubercular Agents; Carcinoma, Hepatocellular; Cell Proliferation; Click Chemistry; Humans; Isoniazid; Liver Neoplasms; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Triazoles; Tumor Cells, Cultured | 2011 |
Editorial: new developments in the search for agents to treat tuberculosis.
Topics: Antitubercular Agents; Carcinoma, Hepatocellular; Cell Proliferation; Humans; Isoniazid; Liver Neoplasms; Mycobacterium tuberculosis; Triazoles | 2013 |
Synthesis of novel 1,2,3-triazole derivatives of isoniazid and their in vitro and in vivo antimycobacterial activity evaluation.
Topics: Animals; Antitubercular Agents; Dose-Response Relationship, Drug; Isoniazid; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles; Tuberculosis, Pulmonary | 2014 |
Preliminary SAR and biological evaluation of antitubercular triazolothiadiazine derivatives against drug-susceptible and drug-resistant Mtb strains.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Drug Resistance, Bacterial; Drug Resistance, Multiple; Hep G2 Cells; Humans; Isoniazid; Mycobacterium tuberculosis; Rifampin; Structure-Activity Relationship; Thiadiazines; Triazoles; Vero Cells | 2017 |
Synthesis and anti-mycobacterial activity of 4-(4-phenyl-1H-1,2,3-triazol-1-yl)salicylhydrazones: revitalizing an old drug.
Topics: Aminosalicylic Acid; Antitubercular Agents; Drug Design; Ethambutol; HEK293 Cells; Humans; Hydrazones; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quantitative Structure-Activity Relationship; Rifampin; Structure-Activity Relationship; Triazoles | 2017 |
Neuropharmacological and molecular docking studies of xanthones from Swertia corymbosa.
Topics: Animals; Anticonvulsants; Anxiety; Electroshock; Epilepsy; Isoniazid; Male; Maze Learning; Mice; Molecular Docking Simulation; Motor Activity; Neuropharmacology; Rotarod Performance Test; Seizures; Serotonin; Swertia; Triazoles; Xanthones | 2018 |
Novel isoniazid embedded triazole derivatives: Synthesis, antitubercular and antimicrobial activity evaluation.
Topics: Animals; Antifungal Agents; Antitubercular Agents; Aspergillus niger; Bacterial Proteins; Drug Design; Gram-Negative Bacteria; Isoniazid; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Oxidoreductases; Protein Binding; RAW 264.7 Cells; Triazoles | 2020 |